Greenwich Lifesciences Inc expected to post a loss of 21 cents a share - Earnings Preview

Greenwich Lifesciences

06/11/2024 23:21

* Greenwich Lifesciences Inc  GLSI.OQ   GLSI.O  is expected
to show no change in quarterly revenue when it reports 
results on November 8 (estimated) for the period ending
September 30 2024
    * 
    * ​LSEG's mean analyst estimate for Greenwich Lifesciences
Inc is
for a loss of 21 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Greenwich
Lifesciences Inc is $38.00​, above​ its last closing price
of $14.42. ​​​

This summary was machine generated November 6 at 23:21 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)